Why Are Black Women Dying of Endometrial Cancer at Twice the Rate of White Women?

The Hidden Crisis of Uterine Cancer

Uterine cancer is the most common gynecologic malignancy in the United States. Its incidence is rising, particularly for aggressive subtypes like serous carcinoma. Black women face a disproportionate burden, dying from uterine cancer at nearly twice the rate of white women. These disparities manifest across the entire patient journey, encompassing delayed diagnoses, limited treatment options, and poorer survivorship outcomes. This reflects a broader failure to address inequities within the healthcare system, exacerbated by systemic racism, socioeconomic barriers, and gaps in research¹.

Why This Matters

The disparities in uterine cancer outcomes among Black women extend beyond access to care. Black women are more likely to develop aggressive forms of the disease and to be diagnosed at later stages, largely due to systemic factors such as inadequate screening protocols and delayed detection. Socioeconomic barriers, provider biases, and environmental exposures further compound these challenges. The inequities in uterine cancer care are not only a reflection of healthcare failings but also a stark indicator of broader societal injustices that require urgent attention.

---

What We Know: The Evidence